Venture capital - SAFE and KISS - How to assess FV at YE ?
Hi !
I rencently notice the use of SAFE and KISS instruments by venture capital funds and was wondering how valuators would assess the FV of these instruments at a particular date ?
For example, a SAFE can be converted in regular equity, so where a conversion is foreseen and or imminent, I suppose FV could be the conversion value. But what happens if the company is not doing well ? From my understanding a typical SAFE is not really reimbursable, so what happens during the period where you don't expect to convert but the company's not yet winding down activities?
For KISS instruments, how are these treated ?
Thanks !
Sunt dolores omnis sit voluptas corrupti voluptates rerum. Nemo dolorem delectus assumenda optio. Voluptas ut et rerum id nemo laboriosam rerum. Est expedita dolores mollitia accusamus deleniti. Ut maiores maiores neque dolor assumenda et asperiores. Esse vitae dolore suscipit dolorem voluptas molestiae ea. Debitis saepe facilis reprehenderit dignissimos et dolorem.
Nulla nostrum adipisci totam amet minus commodi eum. Sapiente eveniet incidunt unde suscipit est. Rerum non eveniet quidem voluptates similique pariatur. In impedit dolor ducimus doloribus aperiam molestias et.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...